Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 15 relevant journals, 20 Conferences, 32 workshops are presently dedicated exclusively to Pharmacovigilance and about 142 articles are being published on Pharmacovigilance.
Pharmacovigilance is the practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse reactions. 5th Global Pharmacovigilance Summit consist of following tracks Pharmacokinetics and Pharmacodynamics, Pharmacy Practices and its Challenges, Pharmacovigilance and Risk Management, Clinical Research and Statistics, Strategies for Growth in Pharma Environment
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Pharmacovigilance is a branch of pharmaceutical sciences which deals with detection, assessment, understanding and prevention of side effects or adverse effects (ADR’s) of the active moiety. In short, it deals with the safety of the drug. According to WHO guidelines Pharmacovigilance ultimate goal is to improve the safe and rationale use of drug which eventually improves the patients care and public care.
The purpose of pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems. Its concerns include herbals, traditional and complementary medicines, blood products, biologicals medical devices and vaccines. The main purpose of pharmacovigilance is to improve the patient's safety and enhance his care in terms of the use of medicines, including paramedical interventions. Pharmacovigilance also supports public health programs by providing reliable information for the efficient assessment of the risk-benefit profile of medicines.
Pharmacovigilance Market Expected to Reach USD 6.10 Billion Globally by 2020, expanding at a CAGR of 14.2% from 2014 to 2020. Various factors such as early detection of suspected as well as unsuspected adverse drug reactions (ADRs), prevention of unnecessary hospitalization of patients and increasing number of clinical trials are expected to drive the growth of the global pharmacovigilance market from 2014 to 2020. the global pharmacovigilance market was valued at USD 2,147.3 million in 2012 and is estimated to reach a market worth USD 5,008.2 million in 2019 at a CAGR of 12.9% from 2013 to 2019.
International symposium and workshops
National workshop on Pharmacovigilance 9th and 10th December 2013 at NIN, Hyderabad
Workshop on pharmacovigilance 16 & 17 February 2013
6th Pharmacovigilance Asia Summit .18 - 19 November, 2015 - Amara Hotel, Singapore
Relevant Society and Associations
This page will be updated regularly.
This page was last updated on July 11, 2020